Format

Send to

Choose Destination
Curr Opin Psychiatry. 2013 Jan;26(1):33-40. doi: 10.1097/YCO.0b013e32835ab4a7.

Fish oil as a management component for mood disorders - an evolving signal.

Author information

1
Black Dog Institute, Sydney, New South Wales, Australia. b.hegarty@unsw.edu.au

Abstract

PURPOSE OF REVIEW:

To overview the theoretical relevance of omega-3 and omega-6 fatty acids in the cause of mood disorders, and focus on evaluating the potential therapeutic role of omega-3 fatty acids.

RECENT FINDINGS:

Numerous studies have documented low omega-3 fatty acid levels in those with depressive disorders, and there are plausible biological explanations as to why reduced omega-3 status may predispose to mood disorders as well as to a range of other conditions. Although early studies evaluating the role of omega-3 preparations as treatments of depression were generally positive, the rate of negative or nondifferential studies has increased in recent years. Recent meta-analyses provide an explanation in suggesting that docosahexaenoic acid-weighted preparations may be ineffective while finding support for eicosapentaenoic acid (EPA)-weighted preparations.

SUMMARY:

There is sufficient indicative data favouring EPA-weighted omega-3 supplementation for those with a depressive mood disorder, particular when fish oil is viewed by patients as 'natural,' it has few side effects and is neuroprotective. Recent meta-analyses inform us that intervention studies should focus on EPA-weighted preparations.

PMID:
23108232
DOI:
10.1097/YCO.0b013e32835ab4a7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center